Scholar Rock Holding buy quelbe60
Start price
29.09.24
/
50%
€7.45
Target price
29.09.25
-
Performance (%)
171.14%
End price
07.10.24
€20.20
Summary
This prediction ended on 07.10.24 with a price of €20.20. With a performance of 171.14% the BUY prediction by quelbe60 was a big success. quelbe60 has 50% into this predictionScholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Scholar Rock Holding | 3.093% | 3.093% | 0.503% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
According to quelbe60 what are the pros and cons of Scholar Rock Holding for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by quelbe60 for this prediction
In the thread Scholar Rock Holding diskutieren
Buy Scholar Rock Holding